Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The aim of this study was to investigate the effect and possible mechanism of all-trans retinoic acid (ATRA) on liver fibrosis induced by common bile duct ligation (CBDL) in rats. Fifty-three female Wistar rats were randomly divided into 5 groups: sham operation group (group J, 5 animals) and groups A, B, C and D (12 animals in each group). The rats in groups A, B, C and D were subjected to CBDL to induce liver fibrosis, while those in group J to sham operation. From the 3rd week the rats in groups B, C and D respectively received daily administration of ATRA via gastric tube at three different doses [0.1, 1.5 and 7.5 mg/kg body weight (BW)]. Animals were sacrificed at 6th week. Rats' liver tissues were observed for pathologic changes under a light microscope. The protein levels of type I collagen (COL I), matrix metalloproteinase-2 (MMP2), MMP13 and tissue inhibitors of metalloproteinase-1 (TIMP-1) in liver tissues were determined by immunohistochemical techniques. The expression levels of TGF-beta1 and CTGF mRNA in liver tissues were detected by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). The results showed that loss of normal hepatic architecture and formation of obvious fibrosis were observed in group A, while ATRA treatment for 4 weeks notably alleviated the pathological changes of hepatocytes. The expression of COL I and TIMP-1 proteins in group A was increased, while decreased in ATRA-treated CBDL groups (P<0.05). ATRA (1.5 and 7.5 mg/kg BW) reduced the expression levels of COL I protein more greatly than that of 0.1 mg/kg BW (P<0.05). ATRA treatment increased the protein levels of MMP2 and MMP13. The expression levels of TGF-beta1 and CTGF mRNA in group A were increased. In comparison with group A, the mRNA levels of TGF-beta1 and CTGF in ATRA-treated CBDL groups were significantly decreased (P<0.05). It was concluded that ATRA could inhibit CBDL-induced liver fibrosis in rats by suppressing the expression of TGF-beta1 and CTGF so as to diminish the inhibition of TIMP-1 on MMP2 and MMP13 and increase the activity of MMP2 and MMP13.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the administration of atRAs in vitro to HSCs and in vivo in cholestatic animal models was linked to an inhibition of pro-fibrotic gene expression (TGF-β, col1α1, αSMA, and MMP-2) [179][180][181][182] and showed protective properties in regard to ECM accumulation.[183][184][185]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [179]
Citations
Cites
Sato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., Matsunaga, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1396 · Cited by 609
Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells
Benyon, R. C., & Arthur, M. J. P. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17552 · Cited by 485
Activation of hepatic stellate cells - a key issue in liver fibrosis
Reeves, H. (2002) · Frontiers in Bioscience · doi:10.2741/reeves · Cited by 423
(2011) · Hepatogastroenterology · doi:10.5754/hge10288 · Cited by 307
Ankoma-Sey, V., & Friedman, S. L. (1998) · Liver Growth and Repair · doi:10.1007/978-94-011-4932-7_20 · Cited by 173
Suppression of experimental hepatic fibrosis by administration of vitamin A.
Senoo, H., & Wake, K. (1985) · PubMed · Cited by 158
Davis, B. H., Kramer, R. T., & Davidson, N. O. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114943 · Cited by 148
Okuno, M. (1997) · Hepatology · doi:10.1053/jhep.1997.v26.pm0009328313 · Cited by 141
Rudi, J., Waldherr, R. Ü., Raedsch, R., & Kommerell, B. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80258-4 · Cited by 129
Davis, B. H., Pratt, B. M., & Madri, J. A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61109-3 · Cited by 127
Research works printed but not linked: 2
- Fu Y, Dan Z L, Tang W X et al. Effect of all-trans retinoic acid on expression of TGF-1, CTGF and Collal in chronic alcoholic liver disease in rats. Shijie Huaren Xiaohua Zazhi, 2006,2:179–183
- Arthur M J P. Collagenases and liver fibrosis. J Hepatol, 1995,22(Suppl 2):43–48
Cited by
Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Khomich, O., Ivanov, A. V., & Bartosch, B. (2019) · Cells · doi:10.3390/cells9010024 · Cited by 224
Regulation of hepatic stellate cells by connective tissue growth factor
Huang, G. (2012) · Frontiers in Bioscience · doi:10.2741/4067 · Cited by 135
“Elevated level of CTGF/CCN2 in experimental animal models of liver fibrosis (29, 30, 32, 41-63)”
BackgroundHe, H., Mennone, A., Boyer, J. L., & Cai, S.-Y. (2011) · Hepatology · doi:10.1002/hep.24047 · Cited by 119
“All-trans retinoic acid (atRA) has also been reported to have antifibrotic effects in bile duct ligation (BDL) rats, but the molecular mechanisms remain to be elucidated.(12) Recently, we reported that RA can repress cytochrome P450 7A1 (CYP7A1) expression in HepG2 cells and in primary human hepatocytes.”
BackgroundThe role of the retinoid receptor, RAR/RXR heterodimer, in liver physiology
Li, B., Cai, S., & Boyer, J. L. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166085 · Cited by 100
Brigstock, D. R. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0043-9 · Cited by 69
“2008), while all-trans retinoic acid exerted anti-fibrotic effects in the liver and was associated with decreased CCN2 and TGF-β production (Wang et al. 2008).”
Background
Metadata
- Authors
- Wang, H., Dan, Z., & Jiang, H.
- Affiliations
- Huazhong University of Science and Technology (CN)
- Tongji Hospital (CN)
- Corresponding author
- Wang, Hui
- Venue
- Journal of Huazhong University of Science and Technology [Medical Sciences]
- Published
- 2008-10
- Volume
- 28
- Issue
- 5
- Pages
- 553-557
- ISSN
- 1672-0733 (ISSN-L)
- 1993-1352
- OpenAlex
- W1504879983
- Cited by
- 25
- References
- 31
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2021: 2 · 2020: 4 · 2019: 2 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 5
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Huazhong University of Science and Technology [Medical Sciences] (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- all-trans retinoic acid, liver fibrosis, common bile duct ligation, TGF-β1, connective tissue growth factor, type I collagen, TIMP-1, MMP-2, MMP-13, matrix metalloproteinases, antifibrotic therapy, biliary obstruction, hepatocyte injury, rats, dose-dependent effects, liver histopathology, gene expression regulation, extracellular matrix
- MeSH terms
- Animals, Common Bile Duct, Female, Ligation, Liver Cirrhosis, Random Allocation, RNA, Messenger, Tretinoin, Rats, Wistar, Tissue Inhibitor of Metalloproteinase-1, Matrix Metalloproteinase 2, Rats, Matrix Metalloproteinase 13, Transforming Growth Factor beta1, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats. https://app.cochat.ai/papers/10.1007/s11596-008-0514-x
- The paper
- Wang, H., Dan, Z., & Jiang, H. (2008). Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats. Journal of Huazhong University of Science and Technology [Medical Sciences]. https://doi.org/10.1007/s11596-008-0514-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.